🌐 EnglishEN

AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

🧪

Trial Match

Clinical trials test new treatments — sometimes the newest options available for a disease. Find trials that are recruiting now, near you. Open one to see its eligibility rules as simple questions to go through with your doctor.

Know your stage or your test results (such as EGFR, HER2 or BRCA)? Match trials to your own profile - nothing you type is saved.

🎯 Match trials to me

17 recruiting trials

for Atrial Fibrillation New Onset

Effects of Left Atrial Appendage Resection and Marshall Ligament Amputation on Clinical Outcome in Patients Undergoing Off-pump Coronary Artery Bypass NCT04220047NA1 site📍 Beijing China National Center for Cardiovascular Diseases · Tests: Left Atrial Appendage Resection and Marshall Ligament Amputation Colchicine's Effect on Inflammatory Markers NCT07287345Phase 41 site📍 Lexington Ayesha Ather · Tests: Colchicine (Colcrys®), Placebo Long Term Evaluation of Cardiac Arrhythmias After Transcatheter Aortic Valve Implantation -The LOCATE Registry NCT06055751n/a2 sites📍 Kansas City📍 Kansas City Kansas City Heart Rhythm Research Foundation · Tests: TAVR Procedure and implantation of Boston Scientific Loop Recorder (LUX-Dx PMA# K193473) Magnesium Prophylaxis for the Prevention of New-Onset Atrial Fibrillation in Critically Ill Patients NCT05829317Phase 44 sites📍 Hamilton📍 Kingston📍 Ottawa Dr. Stephanie Sibley · Tests: Magnesium sulfate, Placebo BurdEn of NEw Onset Atrial FIbrillation in patienTs With Acute Myocardial Infarction NCT04528511n/a5 sites📍 Kaifeng📍 Luoyang📍 Zhengzhou Shanghai 10th People's Hospital · Tests: Continuous Electronic Monitor Anticoagulation for New-Onset Post-Operative Atrial Fibrillation After CABG NCT04045665Phase 3106 sites📍 Little Rock📍 Los Angeles📍 Los Angeles Icahn School of Medicine at Mount Sinai · Tests: Antiplatelet-only strategy, Oral Anticoagulant plus background antiplatelet therapy Left Atrial Strain and Cryptogenic Stroke NCT07224178n/a1 site📍 Pittsburgh University of Pittsburgh Short Term Anti-aRrhythmic Therapy for Post-Operative AF in Cardiac Surgery Patients Pilot Trial NCT05841056Phase 32 sites📍 Hamilton📍 Toronto Population Health Research Institute · Tests: Amiodarone Hydrochloride 200 MG The Impact of LBBAP vs RVP on the Incidence of New-onset Atrial Fibrillation in Patients With Atrioventricular Block NCT06023784NA1 site📍 Beijing Peking Union Medical College Hospital · Tests: left bundle branch area pacing, right ventricular pacing New Onset of Arrhythmia After Patent Foramen Ovale (PFO) Closure NCT06983613n/a2 sites📍 Prague📍 Prague Na Homolce Hospital BoxX-NoAF Clinical Trial NCT06989775NA37 sites📍 Scottsdale📍 Jonesboro📍 San Diego AtriCure, Inc. · Tests: Isolator® Synergy™ EnCompass® Ablation System and AtriClip® LAA Exclusion System The Basel CardioInsightTM - 3D Mapping Study NCT04964765n/a2 sites📍 Sankt Pölten📍 Basel University Hospital, Basel, Switzerland · Tests: Mapping, Computed tomography scan Rate, Rhythm or Risk Control for New-onset Supraventricular Arrhythmia During Septic Shock: a Randomized Controlled Trial NCT04844801NA1 site📍 Paris Assistance Publique - Hôpitaux de Paris · Tests: Risk control strategy, Heart-Rate control strategy:, Rhythm control strategy: Amiodarone-Infused CardiaMend Patches for the Prevention of New-Onset POAF in Cardiac Surgery Subjects NCT06730828Phase 1, Phase 21 site📍 Louisville Helios Cardio Inc. · Tests: The intervention includes Amiodarone-Infused CardiaMend patches (70mg, 150mg and 300mg) Stroke Risk Assessment and Markers of Blood Clotting in Patients With Newly Diagnosed Non-valvular Atrial Fibrillation (NVAF), Who Have Not Received Oral Anticoagulation Therapy (OAC-therapy) Prior to Inclusion NCT06949319n/a1 site📍 Esbjerg Nedim Tojaga Remimazolam for Postoperative Atrial Fibrillation NCT05891145NA1 site📍 Yangzhou Yangzhou University · Tests: Remimazolam, midazolam EMPA-ESUS. a Randomised Control Trial to Investigate the Impact of Empagliflozin on Left Atrial Function in Patients with Embolic Stroke of Undetermined Source NCT06715449Phase 2, Phase 31 site📍 Cambridge University of East Anglia · Tests: Empagliflozin 10 MG
🛡️

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it — not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use · Privacy